Dr Christina Founta receives award for Best Presentation at BSCCP

At the culmination of this year’s BSCCP Conference, Dr Christina Founta was awarded the prize for Best Presentation for her talk on the use of the DYSIS Colposcope in the Test of Cure pathway step.

Dr Founta presented the preliminary results of her investigation into the effectiveness of traditional colposcopy in comparison to DYSIS Colposcopy in the critical “Test of Cure” examination. This test is performed on patients who have received treatment for cervical neoplasia but are still having positive HPV tests and is intended to establish if there is residual disease in the cervix.

Dr Founta, who performed her research at Queen Elizabeth Hospital, Gateshead, presented her startling findings that traditional colposcopy has 0% sensitivity to detecting CIN2+ disease, versus DYSIS Colposcopy which has 80% sensitivity.

The results are highly significant because of the possible implications: Women who are cleared at the Test of Cure stage by traditional colposcopy, but who are actually harbouring CIN disease, are released back to the normal screening interval of 3 years. During this time, the residual disease could progress into more advanced and potential dangerous disease states.

Dr. Founta’s presentation may be viewed here.